Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans

J Immunol. 2013 Feb 1;190(3):977-86. doi: 10.4049/jimmunol.1201331. Epub 2013 Jan 2.

Abstract

We investigated the relationship between varicella zoster virus (VZV)-specific memory CD4(+) T cells and CD4(+)Foxp3(+) regulatory T cells (Tregs) that accumulate after intradermal challenge with a VZV skin test Ag. VZV-specific CD4(+) T cells were identified with a MHC class II tetramer or by intracellular staining for either IFN-γ or IL-2 after Ag rechallenge in vitro. VZV-specific T cells, mainly of a central memory (CD45RA(-)CD27(+)) phenotype, accumulate at the site of skin challenge compared with the blood of the same individuals. This resulted in part from local proliferation because >50% of tetramer defined Ag-specific CD4(+) T cells in the skin expressed the cell cycle marker Ki67. CD4(+)Foxp3(+) T cells had the characteristic phenotype of Tregs, namely CD25(hi)CD127(lo)CD39(hi) in both unchallenged and VZV challenged skin and did not secrete IFN-γ or IL-2 after antigenic restimulation. The CD4(+)Foxp3(+) T cells from unchallenged skin had suppressive activity, because their removal led to an increase in cytokine secretion after activation. After VZV Ag injection, Foxp3(+)CD25(hi)CD127(lo)CD39(hi) T cells were also found within the VZV tetramer population. Their suppressive activity could not be directly assessed by CD25 depletion because activated T cells in the skin were also CD25(+). Nevertheless, there was an inverse correlation between decreased VZV skin responses and proportion of CD4(+)Foxp3(+) T cells present, indicating indirectly their inhibitory activity in vivo. These results suggest a linkage between the expansion of Ag-specific CD4(+) T cells and CD4(+) Tregs that may provide controlled responsiveness during Ag-specific stimulation in tissues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / immunology
  • Antigens, CD / analysis
  • Antigens, Viral / administration & dosage
  • Antigens, Viral / immunology*
  • CD4-Positive T-Lymphocytes / chemistry
  • CD4-Positive T-Lymphocytes / immunology*
  • Female
  • Forkhead Transcription Factors / analysis
  • Herpesvirus 3, Human / immunology*
  • Humans
  • Hypersensitivity, Delayed / immunology
  • Immediate-Early Proteins / administration & dosage
  • Immediate-Early Proteins / immunology*
  • Immunodominant Epitopes / immunology
  • Immunologic Memory
  • Injections, Intradermal
  • Intradermal Tests
  • Ki-67 Antigen / analysis
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Skin / immunology*
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets / chemistry
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes, Regulatory / immunology
  • Tuberculin Test
  • Viral Envelope Proteins / administration & dosage
  • Viral Envelope Proteins / immunology*
  • Young Adult

Substances

  • Antigens, CD
  • Antigens, Viral
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Immediate-Early Proteins
  • Immunodominant Epitopes
  • Ki-67 Antigen
  • Viral Envelope Proteins
  • immediate early protein 63, Human herpesvirus 3